Skip to main content
OpenTrials
Completed

NCT Number: NCT01899976

X-MAS Biliary Study With Covered Biliary Stent

The purpose of this study is to provide safety and efficacy data for the X-Suit NIR® Covered Biliary Metallic Stent for subjects with malignant stricture(s) in the biliary tree. The study is designed to support the regulatory requirement of a 510(k) marketing application in the United States.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hôpital Erasme Brussels (ULB), Brussels, Belgium

Loading trial locations.

About this study

This is a non-randomized, multi-center, prospective, single arm clinical study of the X-Suit NIR® Covered Biliary Metallic Stent for the palliation of malignant strictures in the biliary tree via endoscopic approach.

Adult males and females (≥ 18 years old), with clinical symptoms of biliary obstruction and inoperable extrahepatic biliary obstruction by any malignant process.

The expected duration of this study is approximately 18 months from the time of first subject enrollment to the time of the last subject's 6-month post stent implantation follow-up visit.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 or older.
  • Clinical symptoms of biliary obstruction.
  • Presence of inoperable extrahepatic distal biliary obstruction by any malignant process (the subject not being a surgical candidate based on the finding of a pancreatic mass >2.0cm or a severe medical illness).
  • Subject is willing and able to comply with the study procedures and provide written informed consent to participate in the study.
  • Insured by Social Security (applicable to subjects screened in France).

Exclusion criteria

  • 1. Participation in an Investigational Study within 90 days prior to date of subject consent.
  • Perforation of any duct within the biliary tree. 3. Presence of more than one previously implanted plastic stent. 4. Previous plastic stent implantation less than 2 weeks prior to current procedure.
  • Presence of a metal biliary stent. 6. Presence of any esophageal or duodenal stent. 7. Previous Bilroth II or Roux-en-Y gastric resection, a significant duodenal obstruction or any other altered anatomy which could prevent access to ampulla.
  • Subjects for whom endoscopic procedures are contraindicated. 9. Subjects with known sensitivity to any components of the stent or delivery system.
  • Subjects with active hepatitis or other hepatic diseases that may cause jaundice.
  • Subjects with a WHO performance score of 4 - Bedbound (completely disabled, cannot carry on any self-care, totally confined to bed or chair).
  • Subjects known to be pregnant.

Cholangiographic exclusion criterion:

  • Strictures that cannot be passed by the guide wire or the delivery system.

Treatment and study plan

X-Suit NIR Covered Biliary Stent

Device

Primary outcomes

  1. Maintenance of a total serum bilirubin level ≤ 3.0 mg/dL or a reduction of >30% if baseline value was greater than 3.0 mg/dL

    Time frame: 6 months follow up or prior to death, whichever comes first

    Maintenance of a total serum bilirubin level ≤ 3.0 mg/dL or a reduction of >30% if baseline value was greater than 3.0 mg/dL- outcome

Secondary outcomes

  1. total number of adverse events

    Time frame: 6 months

    total number of adverse events (anticipated and unanticipated)

Sponsors and collaborators

Lead sponsor

Medinol Ltd.

Industry

Registry information

Official study title

A Non-Randomized, Multi-Center, Prospective, Single Arm Clinical Study of the X-SUIT NIR® Covered Biliary Metallic Stent for Palliation of Malignant Strictures in the Biliary Tree Via Endoscopic Approach

Important dates

Study start
2013
Primary completion
2017
Study completion
2017
First posted
Jul 16, 2013
Registry last updated
Apr 13, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.